KPV-10 5mg

Description

KPV Technical Overview

KPV is a synthetic tripeptide consisting of lysine, proline, and valine. Its sequence corresponds to the C-terminal three residues of alpha-melanocyte-stimulating hormone (α-MSH).

The compound has been investigated in experimental research involving inflammatory signaling, intestinal epithelial biology, and short peptide transport.

Preclinical studies have examined KPV-associated changes in inflammatory mediator responses in selected cellular systems.

Compound Specifications

The designation KPV-10 is retained from the product name; it does not establish that the peptide contains ten amino acids.

Storage and Handling

• Follow manufacturer-specific stability conditions.
• Protect from moisture, light, and contamination.
• Use appropriate laboratory peptide handling procedures.

Lyophilized Format

KPV may be manufactured in lyophilized form. Physical characteristics and storage stability depend on the supplied preparation.

Research Use Disclaimer

KPV is not FDA-approved for human therapeutic use. Not intended for human or veterinary administration.

Frequently Asked Questions

What Is KPV?

A synthetic three-amino-acid fragment related to α-MSH.

What Is Its Sequence?

Lys-Pro-Val.

Does KPV Have Ten Residues?

No. KPV is a tripeptide.

What Research Areas Involve KPV?

Inflammatory mediator signaling and epithelial cellular responses.

Research Overview

KPV has been studied in experimental inflammatory signaling research.

Intestinal Epithelial Research

Studies investigate cellular responses in epithelial models.

Inflammatory Signaling

Research examines selected cytokine-associated pathways.

Peptide Transport

Experimental investigations have explored short peptide uptake mechanisms.

Research Applications

References

1. KPV Experimental Research — PubMed.

Certificate of Analysis (COA)

Documentation should verify the KPV sequence, purity, and actual vial content.

Peptide Lives